The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Review and analysis of FDA approved drugs using lipid-based formulations
Open accessAbstract
Lipid-based drug delivery systems (LBDDS) are one of the most studied bioavailability enhancement technologies and are utilized in a number of U.S. Food and Drug Administration (FDA) approved drugs. While researchers have used several general rules of thumb to predict which compounds are likely to benefit from LBDDS, formulation of lipid systems is primarily an empiric endeavor. One of the challenges is that these rules of thumb focus in different areas and are used independently of each other. The Developability Classification System attempts to link physicochemical characteristics with possible formulation strategies. Although it provides a starting point, the formulator still has to empirically develop the formulation. This article provides a review and quantitative analysis of the molecular properties of these approved drugs formulated as lipid systems and starts to build an approach that provides more directed guidance on which type of lipid system is likely to be the best for a particular drug molecule.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With numerous commercial successes, lipid-based drug delivery systems (LBDDS) have a proven track record to improve oral absorption of poorly water-soluble drugs (PWSDs) through a variety of mechanisms including increasing solubility, reducing food-induced exposure variability and improving overall intestinal uptake (Savla et al., 2017).”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Savla et al., 2017
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,417
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,306
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
Pouton, C. W., & Porter, C. J. H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 908
Research works printed but not linked: 11
- Porter CJH., 2007, Oral lipid-based formulations: enhancing the bioavailability of poorly water-soluble drugs, 185
- Griffin B., 2012, Am Pharm Rev
- 10.1097/00007890-199559040-00011 · DOI
- Gao P. MW., 2007, Oral lipid-based formulations enhancing the bioavailability of poorly water soluble drugs
- Martins S, 2007, Int J Nanomed, 2, 595
- 2013, Abelcet®
- Johansen HK, 2014, Cochrane Database Syst Rev, CD000969
- Chen Y-C, 2015, Int J Nanomed, 10, 7265
- Zgair A, 2016, Am J Trans Res, 8, 3448
- Perlin DS., 2004, Curr Opin Investig Drugs, 5, 198
- Yang Z, 2014, Int J Nanomed, 9, 327
Cited by
Sorted by citations
Items 101–200 of 223
Gokulan, K., Kumar, A., Lahiani, M. H., Sutherland, V. L., Cerniglia, C. E., & Khare, S. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa177 · Cited by 16
Okeyo, P. O., Rajendran, S. T., Zór, K., & Boisen, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113850 · Cited by 15
Stanczyk, F. Z., Niu, C., Azen, C. G., Mirkin, S., & Amadio, J. M. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001356 · Cited by 15
Narade, S., & Pore, Y. V. (2019) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2019.90111 · Cited by 15
Artificial lipidation of proteins and peptides: from mechanism to clinical applications
Mu, J., Vong, E., & Carmali, S. (2025) · FEBS Journal · doi:10.1111/febs.70298 · Cited by 17
Sirvi, A., Jadhav, K., & Sangamwar, A. T. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124108 · Cited by 14
Ranganathan, N., & Gayathri, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28814 · Cited by 14
Self-microemulsifying Drug Delivery System for Problematic Molecules: An Update
Singh, D., Tiwary, A. K., & Bedi, N. (2019) · Recent Patents on Nanotechnology · doi:10.2174/1872210513666190619102521 · Cited by 14
Ambati, S., Li, Y., Whittaker, M. K., Kennedy, E. J., Najahi‐Missaoui, W., Lin, X., Lewis, Z., & Meagher, R. B. (2025) · Communications Materials · doi:10.1038/s43246-025-00749-8 · Cited by 14
The expanding role of formulations to enable oral delivery of poorly water-soluble drugs
Ueda, K., Porter, C. J. H., Goodwin, A. K., & Taylor, L. S. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01407-5 · Cited by 13
Lipid-derived renewable amphiphilic nanocarriers for drug delivery, biopolymer-based formulations
Arshad, M., Pradhan, R. A., Zubair, M., & Ullah, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816897-4.00013-8 · Cited by 13
Ahuja, D., Svärd, M., Lusi, M., & Rasmuson, Å. C. (2020) · CrystEngComm · doi:10.1039/d0ce00498g · Cited by 13
Rathod, V., Gajera, B. Y., Pinninti, A. S., Mohammed, I. A., & Dave, R. H. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02589-6 · Cited by 13
Encapsulation of hydrophobic vitamins by polylactide stereocomplexation and their release study
Wojtczak, E., Gadzinowski, M., Makowski, T., Maresz, K., Kubisa, P., Bednarek, M., & Pluta, M. (2018) · Polymer International · doi:10.1002/pi.5674 · Cited by 13
Chase Dosing of Lipid Formulations to Enhance Oral Bioavailability of Nilotinib in Rats
Koehl, N. J., Holm, R., Kuentz, M., & Griffin, B. T. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02841-9 · Cited by 13
Beringhs, A. O., Minatovicz, B., Zhang, G. G. Z., Chaudhuri, B., & Lü, X. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1178-x · Cited by 12
Omeh, R. C., Ugwueze, M. E., Offiah, R. O., Mbah, C. C., Momoh, A. M., Onyishi, I. V., Onunkwo, G. C., & Onyechi, J. O. (2022) · Bio Research Journal/Bio- Research · doi:10.4314/br.v20i3 · Cited by 11
Atovaquone smart lipid system: Design, statistical optimization, and in-vitro evaluation
Rana, H., Patel, D., Thakkar, V. T., & Gandhi, T. R. (2023) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2023.100144 · Cited by 11
Jeong, S.-J., Song, W.-Y., Park, C., & Kim, D. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00656-5 · Cited by 13
Kandagatla, H. P., Kathawala, M. H., Syed, A., Verbić, T. Ž., Avdeef, A., Kuentz, M., & Serajuddin, A. T. M. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103782 · Cited by 10
Choi, M., Lee, J., & Song, I. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00606-7 · Cited by 11
Thermal study and characterization of new cocrystals of ciprofloxacin with picolinic acid
Torquetti, C., Ferreira, P. O., de Almeida, A. C., Fernandes, R. P., & Caires, F. J. (2021) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-020-10479-3 · Cited by 11
Abbasi, S., Higashino, H., Sato, Y., Minami, K., Kataoka, M., Yamashita, S., & Harashima, H. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00197 · Cited by 11
Chauhan, R. (2026) · Frontiers in Nanotechnology · doi:10.3389/fnano.2026.1801422 · Cited by 11
Omachi, Y. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02311-y · Cited by 10
Yoshida, T., & Kojima, H. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00482 · Cited by 10
Neto, A. F. S., Amaral, A. R. D. C., Danda, L. J. D. A., Chaves, L. L., Alves, L. D. S., Soares, M. F. D. L. R., & Soares‐Sobrinho, J. L. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126018 · Cited by 10
Jiang, Q., Jiang, M., Lv, Y., Zhang, X., Wang, S., & Zhao, J. (2025) · RSC Advances · doi:10.1039/d5ra04662a · Cited by 10
Sainz-Ramos, M., Villate-Beitia, I., Gallego, I., Qtaish, N. A., Menéndez, M., Lagartera, L., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111787 · Cited by 10
Ilie, A.-R., Griffin, B. T., Vertzoni, M., Kuentz, M., Cuyckens, F., Wuyts, K., Kolakovic, R., & Holm, R. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1843475 · Cited by 10
Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study
Koehl, N. J., Shah, S. M., Tenekam, I. D., Khamiakova, T., Sauwen, N., Vingerhoets, S., Coppenolle, H., & Holm, R. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03088-8 · Cited by 10
Dhumal, D. M., Patil, P. D., Kulkarni, R. V., & Akamanchi, K. G. (2020) · ACS Omega · doi:10.1021/acsomega.0c04931 · Cited by 9
Ramachandra, D. P., & Sudheer, P. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230112123235 · Cited by 10
Kapoor, D. U., Sharma, D., Gaur, M., Prajapati, B. G., Limmatvapirat, S., & Sriamornsak, P. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385280541231130055458 · Cited by 9
Lu, X., Li, M., Arce, F. A., Ling, J., Setiawan, N., Wang, Y., Shi, X., Campbell, H. R., Nethercott, M. J., Xu, W., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00477 · Cited by 9
Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases
de Camargo, B. A. F., Fonseca‐Santos, B., Carvalho, S. G., Carvalho, G. C., Filippo, L. D. D., Araújo, V. H. S., Duarte, J. L., Silvestre, A. L. P., Bauab, T. M., & Chorilli, M. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2047007 · Cited by 8
Polymer–lipid hybrid nanostructures for drug delivery
Gusmão, L. A., & Tedesco, A. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85754-3.00003-4 · Cited by 8
Vegetable oils as green solvents in the pharmaceutical industry
Cheikhyoussef, N., & Cheikhyoussef, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821885-3.00017-7 · Cited by 8
Pehlivanov, I. (2019) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2019252.2575 · Cited by 8
Ryan, C. D., Griffin, B. T., & O’Shea, J. P. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00106 · Cited by 7
Mazzeti, A. L., Gonçalves, K. R., Boasquívis, P. F., Bahia, M. T., & Mosqueira, V. C. F. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10020050 · Cited by 7
Advances in drug delivery systems for the management of gout and hyperuricemia
Peng, Z., Meng, F., Deng, Q., Huang, Y., Mao, D., Long, Y., Yan, W., Peng, J., Wang, X., & Liu, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1660890 · Cited by 10
Kroll, P., Exner, L., Brandenbusch, C., & Sadowski, G. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00941 · Cited by 7
Exploring Novel Strategies for Lipid-Based Drug Delivery
Kotta, S., Sharma, N., Raturi, P., Aleem, M., & Sharma, R. K. (2018) · Journal of Nanotoxicology and Nanomedicine · doi:10.4018/jnn.2018010101 · Cited by 7
Stereospecific synthesis of phosphatidylglycerol using a cyanoethyl phosphoramidite precursor
Struzik, Z. J., Weerts, A. N., Storch, J., & Thompson, D. H. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104933 · Cited by 7
Ajiboye, A. L., Jacopin, A., Mattern, C., Nandi, U., Hurt, A. P., & Trivedi, V. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02453-z · Cited by 6
Earle, R. R., & Radha, G. V. (2023) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-022-09703-4 · Cited by 6
Oliveira, L. T., Castanheira, R. G., Vilela, J. M. C., Andrade, M. S., de Oliveira, M. A., & Mosqueira, V. C. F. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.465565 · Cited by 6
Evaluation of the dissociation behavior of hydrophobic ion pairs via HPLC analysis
Stengel, D., Nestl, C., Postina, A., Veider, F., Fernández, O., Sandmeier, M., Kwiatkowski, M., Kipura, T., Braun, D. E., & Bernkop‐Schnürch, A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125311 · Cited by 6
Guruge, A. G., Warren, D. B., Benameur, H., Ford, L., Williams, H. D., Jannin, V., Pouton, C. W., & Chalmers, D. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00547 · Cited by 6
Incompatibility of antimalarial drugs: challenges in formulating combination products for malaria
Mhango, E. K. G., Sveinbjörnsson, B. R., Snorradottir, B. S., & Gizurarson, S. S. (2024) · Drug Delivery · doi:10.1080/10717544.2023.2299594 · Cited by 6
Hasan, N. M. Y. (2019) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2019v11i1.28664 · Cited by 6
Hasan, N. M. Y. (2019) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2019v11i3.29732 · Cited by 6
Gong, Z., Tootoonchi, M. H., Fraker, C. A., & Walls, J. D. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121093 · Cited by 6
A Comprehensive Insight on Self Emulsifying Drug Delivery Systems
Nanda, A., & Kadian, R. (2021) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/2667387815666211207112803 · Cited by 6
Hwang, K.-M., Choi, M., Seok, S. H., & Park, E. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121660 · Cited by 6
Naim, J., Sharmin, N., Shuma, M. L., & Halder, S. (2022) · Dhaka University Journal of Pharmaceutical Sciences · doi:10.3329/dujps.v20i3.59804 · Cited by 6
Targeted drug delivery: concepts, approaches, and applications
Russi, M., Marson, D., Laurini, E., & Pricl, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00003-5 · Cited by 5
Karatza, E., Sinha, J., Maglalang, P. D., Edginton, A. N., & González, D. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01418-8 · Cited by 5
Murray, J. D., Bennett-Lenane, H., O’Dwyer, P. J., & Griffin, B. T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00991 · Cited by 5
Kesavan, A., Reddy, U. C., Kurian, J., & Muraleedharan, K. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103439 · Cited by 6
Sirvi, A., Janjal, A., Debaje, S., & Sangamwar, A. T. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125079 · Cited by 5
Kim, J.-S., Ha, E., Park, H., Choi, D. H., Kim, M., & Baek, I. (2019) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-019-00594-4 · Cited by 5
Enhanced Bioavailability and Intestinal Uptake of Nanoparticles After Oral Delivery
Patel, M., & Sawant, K. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-83395-4_21 · Cited by 4
Radha, G. V., Koduru, T. S., Burada, S., & Rajkumar, J. (2019) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2019v11i1.29978 · Cited by 6
Earle, R. R., & Gadela, V. R. (2022) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2022.08.008 · Cited by 4
Islam, M. S., & Mitra, S. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.03.011 · Cited by 4
Chemistry, Isolation, and Pharmaceutical Applications of Inulin
Dangre, P. V., Kotkar, K., Pimple, A., & Meshram, S. S. (2024) · Current Drug Therapy · doi:10.2174/0115748855274579240103042126 · Cited by 4
Prodrugging fungicidal amphotericin B significantly decreases its toxic effects
Štěpánek, O., Parigger, M., Procházková, E., Čmoková, A., Kolařík, M., Dračínská, H., Černá, V., Kalíková, K., Grobárová, V., Černý, J., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117157 · Cited by 4
Kalhapure, R. S., Bolla, P. K., Boddu, S. H. S., & Renukuntla, J. (2019) · Processes · doi:10.3390/pr7080520 · Cited by 4
Izadi, E., Mohammadi, S. S., Ganjalıkhani-Hakemi, M., Eshghi, S., Saremi, L., Saltanatpour, Z., & Hamidieh, A. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177786 · Cited by 4
Rajamohamed, R., & Veerappapillai, S. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01007-w · Cited by 3
Gülmezoğlu, E., Türkyılmaz, G. Y., & Karasulu, H. Y. (2022) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2022.2164588 · Cited by 3
Berroug, L., Essaidi, O., Laaroussi, M., Malqui, H., Anarghou, H., Bellali, F., Fetoui, H., & Chigr, F. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114548 · Cited by 3
Distribution of lamivudine into lymph node HIV reservoir
Wong, A., Chu, Y., Chen, H., Feng, W., Ji, L., Qin, C., Stocks, M. J., Marlow, M., & Gershkovich, P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123574 · Cited by 3
Dong, X., & Nguyen, N. T. D. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124447 · Cited by 3
Luong, A. Q., Le, T. U., Nguyen, T. P. N., Tran, T. H., & Tran, B. N. (2024) · BioNanoScience · doi:10.1007/s12668-024-01687-4 · Cited by 3
Nishiyama, S., Takemoto, Y., Yamanouchi, K., Kondo, K., Kawatsu, S., Maruyama, M., & Higaki, K. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125458 · Cited by 3
Strategies for the Formulation Development of Poorly Soluble Drugs via Oral Route
Shah, S. M., Date, A. A., & Holm, R. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527812172.ch2 · Cited by 3
Impact on Drug Development and Drug Product Processing
Page, S., & Szepes, A. (2021) · Methods and principles in medicinal chemistry · doi:10.1002/9783527823048.ch6 · Cited by 4
New fluorogenic triacylglycerols as sensors for dynamic measurement of lipid oxidation
Handke, M., Beierlein, F., Imhof, P., Schiedel, M., & Hammann, S. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05642-w · Cited by 2
Jin, S. G., Cho, J. H., & Choi, H. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00786-y · Cited by 3
Petřík, J., Rychecký, O., Krejčí, T., Becherová, L., Trunov, D., Prachár, M., Navrátil, O., Žvátora, P., Krejčík, L., Dammer, O., et al. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02430-6 · Cited by 2
Maity, S., Vora, A., Kanhed, A. M., Misra, A. R., & Wairkar, S. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2475333 · Cited by 2
de Paiva, F. C. M., Ferreira, J. P. D. S., Alexandrino-Júnior, F., Chaves, M. H. D. C., Chrisman, E. C. A. N., Sarcinelli, M. A., & Rocha, H. V. A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106989 · Cited by 2
Paulus, F., Bauer‐Brandl, A., Stappaerts, J., & Holm, R. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125725 · Cited by 2
Self-emulsifying drug delivery formulations
Ibrahim, T., El-Megraba, N., & Abdallaha, M. (2018) · Zagazig Journal of Pharmaceutical Sciences/Zagazig Journal of Pharmaceutical Science · doi:10.21608/zjps.2018.38102 · Cited by 2
Impact of a formulation design on resultant dispersions of self-microemulsifying lipid systems
Hasan, N. M. Y. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.110311 · Cited by 1
Gardouh, A. R., Nasef, A. M., Mostafa, Y., & Gad, S. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00411 · Cited by 1
Limited cellular uptake of liposomes: Might thiolated phospholipids hold the key?
Stengel, D., Özdal, Z. D., Truszkowska, M., Saleh, A., Seybold, A., & Bernkop‐Schnürch, A. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124812 · Cited by 1
Cellular Uptake and Trafficking of Lipid Nanocarriers Using High-Resolution Electron Microscopy
Faber, T., & Lamprecht, A. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03061-3 · Cited by 1
Almufarriji, F. M., Alotaibi, B. S., Alamri, A. S., Alkhorayef, N., Alnomasy, S. F., Alqahtani, M., & Alenazy, R. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107485 · Cited by 1
Allıto, A., Önder, A., Önder, F. C., & Erdoğan, M. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11418-w · Cited by 1
Chaves, M. H. D. C., Alexandrino-Júnior, F., Sarcinelli, M. A., Gomes-da-Silva, N. C., Santos-Oliveira, R., Amendoeira, F. C., & Rocha, H. V. A. (2026) · ACS Omega · doi:10.1021/acsomega.5c09971 · Cited by 1
Ryan, C. D., O’Shea, J. P., & Griffin, B. T. (2026) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2026.104262 · Cited by 1
Singh, A., Maheshwari, S., Prajapati, B. G., & Singh, S. A. (2026) · Drying Technology · doi:10.1080/07373937.2026.2664806 · Cited by 1
Understanding Cancer Cell Behavior Through 3D Printed Bone Microenvironments
Luo, Y., Elumalai, A., Humayun, A., & Mills, D. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-23906-0_6 · Cited by 1
Li, Y., Orahoske, C. M., Dano, R., Zhang, W., Li, B., & Su, B. (2021) · Biomedical Chromatography · doi:10.1002/bmc.5169 · Cited by 1
LIPID AS AN EXCIPIENT FOR DESIGN AND DEVELOPMENT OF FORMULATIONS
More, A. V., Dhokchawle, B. V., Tauro, S. J., & Kulkarni, S. V. (2022) · INDIAN DRUGS · doi:10.53879/id.59.07.12199 · Cited by 1
Bioinspired drug delivery therapeutics
Faria, R., Neves, A. R., & Costa, D. R. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00008-4 · Cited by 1
Metadata
- Authors
- Savla, R., Browne, J., Plassat, V., Wasan, K. M., & Wasan, E. K.
- Affiliations
- Catalent (United States) (US)
- Cerenis Therapeutics (France) (FR)
- University of Saskatchewan (CA)
- Corresponding author
- Savla, Ronak
- Venue
- Drug Development and Industrial Pharmacy
- Publisher
- Informa UK Limited
- Published
- 2017-07-06
- Volume
- 43
- Issue
- 11
- Pages
- 1743-1758
- ISSN
- 0363-9045 (ISSN-L)
- 1520-5762
- OpenAlex
- W2732877934
- Cited by
- 225
- References
- 75
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 27 · 2021: 39 · 2020: 42 · 2019: 21 · 2018: 14
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Drug Development and Industrial Pharmacy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Figshare (cc-by)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- lipid-based drug delivery, bioavailability enhancement, FDA-approved drugs, physicochemical properties, molecular properties
- MeSH terms
- Biological Availability, Chemistry, Pharmaceutical, Humans, Lipids, United States, Drug Delivery Systems, Drug Approval
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review